Peritoneal Carcinomatosis: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

Peritoneal carcinomatosis represents a heterogeneous group of malignancies in which local tumor burden, primary-site biology, and systemic disease behavior jointly determine prognosis. This critical narrative review examines the therapeutic contribution of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC), with particular attention to patient selection and randomized evidence. PubMed/MEDLINE, full reports of pivotal trials, and international consensus documents available through 2026 were examined, prioritizing comparative survival, perioperative harms, and clinical applicability. Complete macroscopic cytoreduction is a central condition for meaningful disease control in suitable patients, but the benefit attributable to HIPEC is not uniform. In colorectal peritoneal metastases, PRODIGE 7 did not establish an overall survival advantage for short-duration oxaliplatin HIPEC, whereas the CAIRO6 trial did not support routine perioperative systemic chemotherapy for all resectable cases. In ovarian cancer, benefit appears most reproducible at interval cytoreduction, with more selective evidence in recurrence. Recent gastric trials found no survival benefit and substantial treatment burden. For pseudomyxoma peritonei and selected peritoneal mesothelioma, spe cialized CRS-HIPEC remains strongly supported by consensus despite low-certainty comparative evidence. Decisions should integrate resectability, disease distribution, expected morbidity, tumor-specific evidence, and patients' priorities.

Authors

Institutions

Publication Details

Journal
International Health Sciences Review
Published
2026-11-13
DOI
https://doi.org/10.70164/ihsr.v2i6.270
Primary Topic
Intraperitoneal and Appendiceal Malignancies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Peritoneal Carcinomatosis: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

Eduardo Moreschi, Matheus Bovolim Lourenço, Giulia Miquelão Sala, Fernanda Ceron Damiani et al.
International Health Sciences Review
Intraperitoneal and Appendiceal Malignancies
article

Peritoneal Carcinomatosis: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

Eduardo Moreschi, Matheus Bovolim Lourenço, Giulia Miquelão Sala, Fernanda Ceron Damiani, Rafael de Souza Pinto Paiva Diniz, Vitor dos Santos Barbosa, Milena Rizzo, Arthur Schmidt Strelow, João Henrique Pontalti
article en

Abstract

Peritoneal carcinomatosis represents a heterogeneous group of malignancies in which local tumor burden, primary-site biology, and systemic disease behavior jointly determine prognosis. This critical narrative review examines the therapeutic contribution of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC), with particular attention to patient selection and randomized evidence. PubMed/MEDLINE, full reports of pivotal trials, and international consensus documents available through 2026 were examined, prioritizing comparative survival, perioperative harms, and clinical applicability. Complete macroscopic cytoreduction is a central condition for meaningful disease control in suitable patients, but the benefit attributable to HIPEC is not uniform. In colorectal peritoneal metastases, PRODIGE 7 did not establish an overall survival advantage for short-duration oxaliplatin HIPEC, whereas the CAIRO6 trial did not support routine perioperative systemic chemotherapy for all resectable cases. In ovarian cancer, benefit appears most reproducible at interval cytoreduction, with more selective evidence in recurrence. Recent gastric trials found no survival benefit and substantial treatment burden. For pseudomyxoma peritonei and selected peritoneal mesothelioma, spe cialized CRS-HIPEC remains strongly supported by consensus despite low-certainty comparative evidence. Decisions should integrate resectability, disease distribution, expected morbidity, tumor-specific evidence, and patients' priorities.

International Health Sciences ReviewVol. 2(6)
Univates (BR), Universidade de Taubaté (BR), Universidade Feevale (BR), Centro Universitário Cesumar (BR), Universidade de Caxias do Sul (BR), Universidade do Vale do Rio dos Sinos (BR)
Good health and well-being
Intraperitoneal and Appendiceal Malignancies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon